Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 65

Using methylprednisolone to prevent kidney injury during heart surgery

Official title: Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass: A Randomized Double-Blinded Clinical Study

Run by Ain Shams University · NCT06917859 · Data updated 2026-11-12

This study is testing if giving a single dose of methylprednisolone during heart surgery can help prevent kidney injury after the operation.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment170 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Cairo, Abbasia)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedFebruary 1, 2026
Study endsDecember 1, 2026
Registry record updatedApril 9, 2025
Trial IDNCT06917859 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 scheduled for elective cardiac surgeries requiring cardiopulmonary bypass with an ASA score of III-IV.

Probably not a fit

Patients with a history of renal dysfunction, severe hepatic diseases, or those undergoing urgent surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of a single dose of methylprednisolone administered during cardiac surgeries that require cardiopulmonary bypass (CPB) in reducing the incidence of postoperative acute kidney injury (AKI). Patients will be randomly assigned to receive either methylprednisolone or a placebo after anesthesia induction and before CPB initiation. The primary outcome will be the occurrence of AKI within seven days post-surgery, assessed using the RIFLE criteria, while secondary outcomes will include hyperglycemia, ICU stay duration, hospital length of stay, and other postoperative complications.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the risk of acute kidney injury in patients undergoing cardiac surgery, leading to better postoperative outcomes.

How similar studies have gone: While the use of corticosteroids in surgical settings has been explored, this specific prophylactic approach for renal protection during cardiac surgeries is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-65 years.
2. Sex: Both sexes.
3. Patients with American Society of Anesthesiologists (ASA) score III-IV.
4. Patients scheduled for any kind of elective cardiac surgical procedure requiring cardiopulmonary bypass (e.g., coronary artery bypass grafting (CABG), valve repair/replacement, or combined procedures (

Exclusion Criteria:

1. Declining to give written informed consent.
2. History of allergy to the medications used in the study.
3. Diabetic patients with HbA1C \>6.5
4. Moderate to severe hepatic diseases (Child B-C)
5. Hepatic dysfunction: INR \> 1.5, serum albumin \< 2.9 g%.
6. Renal dysfunction (serum Creatinine level \>1.3 mg/dl, or GFR \< 80 ml/min./1.73/m2
7. Patients with a recent history of AKI.
8. Patients undergoing urgent cardiac surgery.
9. Patients undergoing cardiac surgeries with deep hypothermic total circulatory arrest.
10. Planned off-pump procedure.
11. Any cardiac surgery exceeds 45 minutes on Aortic cross clamp.
12. Patients requiring high doses of inotropes and/or vasopressors intraoperative or postoperative (high-dose dopamine is defined as peak doses of \>15 μg/kg/min, high-dose norepinephrine is defined as peak dose \>0.1 μg/kg/min, high-dose epinephrine is defined as peak dose \>0.1 μg/kg/min)
13. Delayed extubation for more than 6 hours postoperative.
14. Patients developed postoperative complications as (septic shock and bleeding)

Where it's running

  • Ain Shams University
    Cairo, Abbasia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.